Nu-Med Plus Inc NUMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.07
- Day Range
- $0.07–0.07
- 52-Week Range
- $0.01–0.09
- Bid/Ask
- $0.04 / $0.05
- Market Cap
- $5.56 Mil
- Volume/Avg
- 12,500 / 70,732
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Nu-Med Plus Inc is an medical device company principally engaged in the design, innovation, development, enhancement, and commercialization of beginning, early, and selective later-stage quality medical devices. It focuses on the formulation of Nitric Oxide powder, which is a desktop generator device which delivers inhaled Nitric Oxide to replace expensive pressurized canisters and a mobile rechargeable device to deliver inhaled Nitric Oxide gas to offer solutions to hospitals, health systems and medical community throughout the world.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- —
- Total Number of Employees
- 2
- Website
- —
Valuation
|
Metric
|
NUMD
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
NUMD
Financial Strength
|
Metric
|
NUMD
|
|---|---|
Quick Ratio | 0.04 |
Current Ratio | 0.08 |
Interest Coverage | −24.11 |
Quick Ratio
NUMD
Profitability
|
Metric
|
NUMD
|
|---|---|
Return on Assets (Normalized) | −206.87% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
NUMD
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Tvjvnzn | Xwnkky | $185.4 Bil | |
SYK
| Stryker Corp | Gzlhlskbwx | Pbxt | $128.2 Bil | |
BSX
| Boston Scientific Corp | Rxsjhvqsv | Ftvdj | $107.7 Bil | |
MDT
| Medtronic PLC | Kdtkkmw | Tqlgxl | $105.2 Bil | |
DXCM
| DexCom Inc | Mjkxdkpv | Lnd | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Qvwlvccqh | Jpvlkl | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Dhgxhqlqt | Yklx | $24.6 Bil | |
ALGN
| Align Technology Inc | Pjmbrdyx | Jmwccf | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Rtbdwgvjw | Yyhzs | $18.7 Bil | |
PODD
| Insulet Corp | Bgvrvswcvd | Rtndyx | $11.5 Bil |